Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISCOVER: Influence of Body Weight on Aspirin-triggered Specialized Pro-resolving Mediators
NCT04697719Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Nov 2021
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, sponsored by NYU Langone Health. Started Nov 2021; status: completed.
02
Drugs
aspirin
Beyond the preview
Go deeper on NCT04697719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04697719.